Discovery of novel Quinazoline-based KRAS G12C inhibitors as potential anticancer agents (vol 71, 116962, 2022)

被引：0
|
作者：
Li, Ling [1 ,2 ]
Zhao, Huiting [2 ]
Peng, Xiaopeng [3 ]
Liu, Jin [2 ]
Mai, Ruiyao [2 ]
Chen, Jingxuan
Lin, Lin [4 ]
Chen, Ting [4 ]
Yan, Jun [5 ,6 ]
Shi, Jiaolong [5 ,6 ]
Chen, Jianjun [2 ,5 ,6 ]
机构：
[1] Sun Yat Sen Univ, Affiliated Hosp 8, Shenzhen 518033, Peoples R China
[2] Southern Med Univ, Sch Pharmaceut Sci, Guangdong Prov Key Lab New Drug Screening, Guangzhou 510515, Peoples R China
[3] Gannan Med Univ, Coll Pharm, Ganzhou 314000, Peoples R China
[4] Southern Med Univ, Nanfang Hosp, Dept Stomatol, Guangzhou 510515, Peoples R China
[5] Southern Med Univ, Dept Gen Surg, Guangzhou 510515, Guangdong, Peoples R China
[6] Southern Med Univ, Nanfang Hosp, Sch Clin Med 1, Guangdong Prov Key Lab Precis Med Gastrointestinal, Guangzhou 510515, Guangdong, Peoples R China
来源：
BIOORGANIC & MEDICINAL CHEMISTRY | 2024年 / 111卷
关键词：
D O I：
10.1016/j.bmc.2024.117840
中图分类号：
Q5 [生物化学]; Q7 [分子生物学];
学科分类号：
071010 ; 081704 ;
摘要：
引用
收藏
页数：1
相关论文
共 43 条
  • [1] Discovery of novel Quinazoline-based KRAS G12C inhibitors as potential anticancer agents
    Li, Ling
    Zhao, Huiting
    Peng, Xiaopeng
    Liu, Jin
    Mai, Ruiyao
    Chen, Jingxuan
    Lin, Lin
    Chen, Ting
    Yan, Jun
    Shi, Jiaolong
    Chen, Jianjun
    BIOORGANIC & MEDICINAL CHEMISTRY, 2022, 71
  • [2] Discovery of novel quinazoline-based covalent inhibitors of KRAS G12C with various cysteine-targeting warheads as potential anticancer agents
    Li, Ling
    Zhao, Huiting
    Liao, Hui
    Chen, Jingxuan
    Liu, Jin
    Chen, Jianjun
    BIOORGANIC CHEMISTRY, 2021, 110
  • [3] Potent and Selective Covalent Quinazoline Inhibitors of KRAS G12C
    Zeng, Mei
    Lu, Jia
    Li, Lianbo
    Feru, Frederic
    Quan, Chunshan
    Gero, Thomas W.
    Ficarro, Scott B.
    Xiong, Yuan
    Ambrogio, Chiara
    Paranal, Raymond M.
    Catalano, Marco
    Shao, Jay
    Wong, Kwok-Kin
    Marto, Jarrod A.
    Fischer, Eric S.
    Janne, Pasi A.
    Scott, David A.
    Westover, Kenneth D.
    Gray, Nathanael S.
    CELL CHEMICAL BIOLOGY, 2017, 24 (08): : 1005 - +
  • [4] Farnesyltransferase inhibitors show synergistic anticancer effects in combination with novel KRAS G12C inhibitors
    Timar, Jozsef
    Baranyi, Marcell
    Molnar, Eszter
    Randelovic, Ivan
    Cserepes, Mihaly
    Tovari, Jozsef
    Hegedus, Balazs
    CANCER RESEARCH, 2024, 84 (07)
  • [5] Discovery of New Quinazoline-Based Anticancer Agents as VEGFR-2 Inhibitors and Apoptosis Inducers
    M. F. Ahmed
    A. S. Khalifa
    E. M Eed
    Russian Journal of Bioorganic Chemistry, 2022, 48 : 739 - 748
  • [6] Discovery of New Quinazoline-Based Anticancer Agents as VEGFR-2 Inhibitors and Apoptosis Inducers
    Ahmed, M. F.
    Khalifa, A. S.
    Eed, E. M.
    RUSSIAN JOURNAL OF BIOORGANIC CHEMISTRY, 2022, 48 (04) : 739 - 748
  • [7] Discovery of KRas G12C-IN-3 and Pomalidomide-based PROTACs as degraders of endogenous KRAS G12C with potent anticancer activity
    Li, Ling
    Wu, Yinrong
    Yang, Zichao
    Xu, Chenglong
    Zhao, Huiting
    Liu, Jin
    Chen, Jingxuan
    Chen, Jianjun
    BIOORGANIC CHEMISTRY, 2021, 117
  • [8] Discovery of KRas G12C-IN-3 and Pomalidomide-based PROTACs as degraders of endogenous KRAS G12C with potent anticancer activity (vol 117, 105447, 2021)
    Li, Ling
    Wu, Yinrong
    Yang, Zichao
    Xu, Chenglong
    Zhao, Huiting
    Liu, Jin
    Chen, Jingxuan
    Chen, Jianjun
    BIOORGANIC CHEMISTRY, 2024, 150
  • [9] Discovery of potent CNS-penetrant covalent KRAS G12C inhibitors
    Bae, Jae Hyun
    Lew, Erin D.
    Feng, Jun
    Gonzalez-Lopez, Marcos
    Oh, Joanne
    Fagan, Patrick
    Salie, Matt
    Isley, Nick
    Lam, Richard
    Irimia, Adriana
    Nevarez, Robin
    Lin, Bingzhen
    Congdon, Taylor
    Zhang, Jingchuan
    Xuan, Dawei
    Chen, Ping
    Vernier, Jean-Michel
    Shoemaker, Robert
    CANCER RESEARCH, 2022, 82 (12)
  • [10] Novel natural inhibitors targeting KRAS G12C by computational study
    Jiang, Yuting
    Chen, Wanting
    Wang, Xinhui
    Zhou, Baolin
    Xie, Haoqun
    Hou, Yuanyuan
    Guo, Zhen
    Yu, Bo
    Zhong, Sheng
    Su, Xing
    ANTI-CANCER DRUGS, 2022, 33 (09) : 779 - 788
12345